What Happened? A number of stocks fell in the afternoon session after major indices pulled back from record highs reached the ...

Shares of solar tracking systems manufacturer Array (NASDAQ:ARRY) jumped 6.9% in the afternoon session after the stock hit a ...

Array BioPharma has been weighing a potential sale for years, and now that it’s inked an $11.4 billion deal with Pfizer, the company’s top execs stand to reap some hefty payouts. Really hefty, in the ...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few ...

Array allegedly sold credit data to shady end-users and listed an employee's dad's tea shop as a growing customer, a former exec alleged.

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Array (NYSE:AD) and its peers. The sector is a tale of two cities.

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Jack Newsham Every time Jack publishes a story, you’ll get an alert straight to your inbox!